↗7 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.5MSold on the market
1Companies
Oct 28, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202616:03 | Oct 26, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $20.00 | −821 | 54,513 | -1% | −$16K | ||
| Oct 16, 202616:10 | Oct 14, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $17.35 | −775 | 55,334 | -1% | −$13K | ||
| Oct 5, 202617:11 | Oct 1, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $18.96 | −370 | 56,109 | -1% | −$7K | ||
| Sep 17, 202616:15 | Sep 16, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $20.13 | −30,779 | 56,479 | -35% | −$620K | ||
| Sep 15, 202616:15 | Sep 14, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $15.52 | −775 | 86,382 | -1% | −$12K | ||
| Sep 10, 202616:30 | Sep 9, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $18.46 | −36,870 | 87,157 | -30% | −$681K | ||
| Sep 3, 202618:15 | Sep 2, 2026 | BBNXBeta Bionics, Inc. | Chief Commercial Officer | S · Sell | $19.11 | −5,327 | 124,027 | -4% | −$102K |